Table 1.
Characteristics of all 175 patients with respect to age, tumor size, lymph nodes, HER2/neu status, hormone receptor, complete remission/relapse/progress, chemotherapy
| Total patients | 175 |
| Mean age | 55 |
| Tumor size | |
| T1 | 91 (52%) |
| T2> | 67 (38%) |
| n.a. | 17 (10%) |
| Lymph node | |
| N0 | 103 (59%) |
| N1> | 56 (32%) |
| n.a. | 16 (9%) |
| Her2/neu status | |
| Negative | 83 (48%) |
| Positive | 42 (24%) |
| n.a. | 50 (28%) |
| Hormone receptor | |
| Negative | 9 (5%) |
| Positive | 155 (89%) |
| n.a. | 11 (6%) |
| Relapse/CR | |
| Relapse | 43 (25%) |
| CR | 132 (75%) |
| n.a. | 0 (0%) |
| Chemotherapy | |
| Adj | 73 (42%) |
| Neo | 41 (23%) |
| None | 46 (26%) |
| n.a. | 15 (9%) |
n.a. not analyzed, CR complete remission, adj adjuvant, neo neoadjuvant